Cytek BioSciences Inc (NASDAQ: CTKB) on Tuesday, soared 4.54% from the previous trading day, before settling in for the closing price of $5.29. Within the past 52 weeks, CTKB’s price has moved between $2.37 and $7.30.
A company in the Healthcare sector has jumped its sales by 18.28% annually for the last half of the decade. The company achieved an average annual earnings per share of -182.29%. With a float of $116.00 million, this company’s outstanding shares have now reached $127.86 million.
Cytek BioSciences Inc (CTKB) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Cytek BioSciences Inc is 9.28%, while institutional ownership is 62.81%. The most recent insider transaction that took place on Jun 02 ’25, was worth 97,300. In this transaction Chief Financial Officer of this company bought 35,000 shares at a rate of $2.78, taking the stock ownership to the 55,746 shares.
Cytek BioSciences Inc (CTKB) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.12 earnings per share (EPS) for the period topping the consensus outlook (set at 0.1) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -182.29% per share during the next fiscal year.
Cytek BioSciences Inc (NASDAQ: CTKB) Trading Performance Indicators
Cytek BioSciences Inc (CTKB) is currently performing well based on its current performance indicators. A quick ratio of 4.48 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Cytek BioSciences Inc (CTKB)
Let’s dig in a bit further. During the last 5-days, its volume was 3.37 million. That was better than the volume of 1.04 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 71.17%.
During the past 100 days, Cytek BioSciences Inc’s (CTKB) raw stochastic average was set at 78.96%, which indicates a significant increase from 73.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.39 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.08, while its 200-day Moving Average is $3.89. However, in the short run, Cytek BioSciences Inc’s stock first resistance to watch stands at $5.73. Second resistance stands at $5.92. The third major resistance level sits at $6.23. If the price goes on to break the first support level at $5.22, it is likely to go to the next support level at $4.90. Assuming the price breaks the second support level, the third support level stands at $4.71.
Cytek BioSciences Inc (NASDAQ: CTKB) Key Stats
Market capitalization of the company is 707.09 million based on 127,865K outstanding shares. Right now, sales total 200,450 K and income totals -6,020 K. The company made 52,290 K in profit during its latest quarter, and -5,480 K in sales during its previous quarter.
